Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report

Autores

  • Giulia Eduarda Turra Aimi
  • Guilherme Rasia Bosi
  • Larissa Beatriz Guerra Universidade de Caxias do Sul
  • Lessandra Michelin

Palavras-chave:

#covid19

Resumo

Immune thrombocytopenic purpura (ITP), an autoimmune disorder, has been documented as a result of SARS-CoV-2 infection and a vaccination side effect. The COVID-19 pandemic has led to the creation of CoronaVac vaccine and has been widely administered in Brazil.

 Patient, in the case, is an 82-years-old female who received the vaccine two days before an acute episode of gingivorrhagia and diffuse cutaneous petechiae. Other exams were made to look for other causes of secondary thrombocytopenia and all the results were normal.  The patient showed improvement on the platelet levels three day after the beginning of the treatment with high dosage methylprednisolone.

Knowing that other kinds of vaccine can generate ITP, the SARS-CoV-2 vaccine could be related to the symptoms.

Downloads

Não há dados estatísticos.

Downloads

Publicado

2023-03-03

Como Citar

1.
Turra Aimi GE, Bosi GR, Guerra LB, Michelin L. Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report. Clin Biomed Res [Internet]. 3º de março de 2023 [citado 29º de março de 2024];42(4). Disponível em: https://seer.ufrgs.br/index.php/hcpa/article/view/121930

Artigos mais lidos pelo mesmo(s) autor(es)

Artigos Semelhantes

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.